quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·57d
PRRelease
Kairos Pharma Ltd. logo

Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics

KAPA· Kairos Pharma Ltd.
Health Care
Original source

Companies

  • KAPA
    Kairos Pharma Ltd.
    Health Care

Related

  • PR9d
    Kairos Pharma Recognized with Pinnacle Award for Excellence in Healthcare Innovation
  • SEC22d
    SEC Form 424B3 filed by Kairos Pharma Ltd.
  • SEC22d
    SEC Form 424B3 filed by Kairos Pharma Ltd.
  • SEC23d
    SEC Form 10-K filed by Kairos Pharma Ltd.
  • SEC53d
    Kairos Pharma Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
  • PR53d
    Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
  • SEC57d
    Kairos Pharma Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC88d
    SEC Form EFFECT filed by Kairos Pharma Ltd.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022